| Name | Title | Contact Details |
|---|
NueHealth is building a nationwide system of clinically integrated provider networks that puts healthcare into the hands of consumers. With a vast network of purpose-driven surgical centers and hospitals, NueHealth connects providers directly to consumers and aids them in delivering value-based payment options and improved outcomes. To deliver this improved value, NueHealth leverages proprietary technologies, online platforms, bundled payments and targeted programs and services. NueHealth gives providers and payors the tools and resources to stay ahead of healthcare’s continued evolution, while giving employers, insurance companies and patients access to a simplified model and affordable, high-quality, streamlined care.
Brooks Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Brooks Memorial Hospital is based in Dunkirk, NY. You can find more information on Brooks Memorial Hospital at www.brookshospital.org
Smc Health Resources Inc is a Fairfield, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cancer CarePoint Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Cancer CarePoint Inc is based in Decatur, GA. You can find more information on Cancer CarePoint Inc at www.cancercarepoint.com
Immune Pharmaceuticals applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company’s lead product candidate, bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma. The Company is evaluating the use of its NanomAb® platform, a second generation antibody drug conjugate technology, with chemotherapeutics in order to enhance their safety and efficacy profiles by delivering the medicines directly to cancer cells. The Company’s growing oncology pipeline also includes proprietary antibodies and, clinical-stage small molecules that have been shown activity in a variety of solid tumors. Immune is headquartered in the U.S., with its primary research and development facilities in Israel.